Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

MGMA calls for HIPAA 5010 transition strategy

In a testimony before the National Committee on Vital and Health Statistics (NCVHS) Subcommittee on Standards last week, the Medical Group Management Association (MGMA) called for a federal strategy to ensure providers and trading partners are prepared for the transition to Version 5010 of the HIPAA electronic transaction standards.

RSNA Foundation awards $2.7M in grants

The RSNA Research and Education Foundation will fund 74 grants totaling nearly $2.7 million in 2011, the largest amount ever granted by the foundation in a single year.

The Handheld Ultrasound Revolution

Handheld ultrasound devices have become a game changer due to their ability to facilitate rapid diagnoses and make imaging more accessible and immediate.

Bio-Tech: PET to outpace SPECT market in coming years

The U.S. market for SPECT and PET systems will increase nearly six-fold over the next seven years as new products are introduced to the market, according to a Bio-Tech Systems report.

Alabama launches cancer network for underserved areas

The University of Alabama at Birmingham (UAB) Comprehensive Cancer Center and UAB Medicine have developed the UAB Cancer Care Network to bring care to cancer patients who do not live near a major academic medical center, giving patients an opportunity to stay close to home while giving physicians and nurses access to leading cancer research.

ACR, providers react to media reports on chest CT scans

While applauding the intent of Medicares Hospital Compare quality measurement program, radiology stakeholders questioned the medias interpretation of the data and the relevance of 2008 statistics.

Once-weekly type 2 diabetes drug gains EU nod

Eli Lilly, along with Amylin Pharmaceuticals and Alkermes, has announced that the European Commission has granted marketing authorization to Bydureon (exenatide 2 mg powder and solvent for prolonged release suspension for injection).

Elekta to buy Nucletron for $524M

Elekta has signed a definitive agreement to acquire Nucletron for EUR365 million ($524.39 million U.S.) in cash. After the aquisition is completed, Elekta said it will offer radiotherapy planning and delivery technologies with the addition of Nucletron's brachytherapy treatment planning and delivery systems.

Around the web

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.